Successful development of bacteriocins into therapeutic formulation for treatment of MRSA-skin infection in a murine model
The emergence of antibiotic resistant pathogens has caused a serious world-wide problem in infection treatments in recent years. One of these pathogens is the methicillin-resistant Staphylococcus aureus (MRSA) which is a major cause of skin and soft tissue infections. Alternative strategies and novel sources of antimicrobials to solve antibiotic resistance …